Status:
UNKNOWN
Prevention of Epilepsy by Reducing Neonatal Encephalopathy
Lead Sponsor:
Thayyil, Sudhin
Collaborating Sponsors:
University College, London
University of Oxford
Conditions:
Neonatal Encephalopathy
Epilepsy
Eligibility:
All Genders
16-50 years
Phase:
NA
Brief Summary
The aim of the study is to examine if a pragmatic, evidenced based and generalisable intrapartum care bundle involving birth companions and empowering mothers will reduce birth injury-related epilepsy...
Detailed Description
Epilepsy is a condition where individuals are prone to recurrent epileptic seizures; which means a change in the electrical activity of the brain resulting in a change in behaviour or movement. Epilep...
Eligibility Criteria
Inclusion
- All pregnant women delivering at 36 weeks or later
Exclusion
- Premature deliveries
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04054453
Start Date
March 1 2020
End Date
October 30 2024
Last Update
August 4 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Bangalore Medical College
Bangalore, India
2
Calicut Medical College
Calicut, India
3
Karnataka Institute of Medical Sciences
Hubbali, India
4
Sudhin Thayyil
London, United Kingdom